










The 6-minute walk test (6MWT) measures the maximum distance that a person can walk in 6 
minutes. The test is gaining popularity because it assesses the functional capacity of different 
patients and is considered a simple, safe, valid, inexpensive, and noninvasive cardiopulmonary 
test. Objective: The aim of this review was to investigate the applicability of the six-minute walk 
test in stroke survivors. Method: A literature search of MedLine (PubMed) databases dating 
from January 1, 2000 to April 16, 2013 was performed. The search terms used were stroke (or 
cerebrovascular accident or hemiplegia) and walking (mobility limitation). Author number one 
reviewed the titles and/or abstracts of displayed articles and determined their relevance to this 
review. Full text copies of relevant articles were obtained. Reference lists were screened for 
identification of other relevant articles. Only articles written in English were included in this review. 
Results: The 31 included studies were divided into 9 randomized controlled trials, 2 case-control 
studies, 5 prospective studies, and 15 cross-sectional studies and involved 1,824 surviving stroke 
patients, 146 healthy controls, and 38 Multiple Sclerosis patients. Conclusion: The 6MWT is useful 
in evaluating de functional capacity of patients with stroke, however, it should be used along 
with other assessment tools to determine the general profile of these patients. More studies are 
necessary to verify the factors that influence the test results and as a way to supplement them.
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Uso do teste de caminhada de seis minutos para avaliar a 
capacidade de deambulação em pacientes com acidente 
vascular cerebral
RESUMO
O teste de caminhada de 6 minutos (TC6) mede a distância máxima que uma pessoa pode 
caminhar em 6 minutos. O teste está ganhando popularidade porque avalia a capacidade do 
estado funcional dos pacientes com diferentes patologias e é considerando simples, seguro, 
válido, barato e não invasivo. Objetivo: O objetivo desta revisão foi investigar a aplicabilidade do 
teste de caminhada de seis minutos em sobreviventes de AVC. Método: A pesquisa bibliográfica 
foi realizada na base de dados MedLine (PubMed) de 1 de Janeiro de 2000 a Abril, 16 2013 
Os termos de pesquisa utilizados foram AVC (acidente vascular cerebral e/ou hemiplegia) e 
caminhada (limitação da mobilidade). O primeiro autor revisou os títulos e/ou resumos de 
artigos encontrados e determinou relevância para a revisão. Cópias de texto completo de artigos 
relevantes foram obtidas. Após a leitura foram selecionados os artigos mais relevantes. Apenas 
artigos escritos em Inglês foram incluídos nesta revisão. Resultados: Os 31 estudos incluídos 
foram divididos em 9 estudos de ensaio clinico randomizado, 2 estudos caso-controle, 5 estudos 
prospectivos e 15 estudos transversais e envolveu 1.824 pacientes sobreviventes de AVC, 146 
controles saudáveis e 38 pacientes com Esclerose Múltipla. Conclusão: O TC6 é útil para avaliar a 
capacidade de funcional em pacientes com acidente vascular cerebral, no entanto deve ser usado 
em conjunto outras ferramentas de avaliação para determinar o perfil geral desses pacientes. Mais 
estudos são necessários para verificar os fatores que influenciam o resultado do teste e a forma 
de complementá-lo.
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BACKGROUND
Originally developed to assess cardiores-
piratory and cardiovascular endurance, the 
6-minute walk test (6MWT) measures the 
maximum distance that a person can walk in 6 
minutes.1 Primarily, it was developed as a tool 
for assessing functional capacity in patients 
with cardiovascular and pulmonary diseases.2 
The test is gaining popularity because assesses 
the patients’ functional capacity and is consi-
dered a simple, safe, valid, inexpensive, and 
noninvasive cardiopulmonary test.1
The 6MWT has been used to investigate 
endurance and correlates well with measu-
rements of impairment in daily life activities 
because it is a general indicator of overall phy-
sical performance, morbidity, and mortality. 
Performance of the 6MWT has been shown 
useful in investigating older adults,3 patients 
with pulmonary hypertension,4 patients with 
severe chronic obstructive disease,5 advanced 
heart failure6 and neurological disorders such 
as stroke,7 Parkinson’s,8 and Multiple Sclerosis.7
In patients with neurological disorders it 
is common to observe some deterioration in 
their mobility that results in lingering physical 
impairments, a sedentary lifestyle, a decline in 
cardio-respiratory fitness; these have been rela-
ted to a higher risk of a new stroke and stroke 
mortality.9 Another problem is the fatigue after 
stroke that presents high incidence and that 
appears to be related to depression, chronic 
pain, sleep disturbances, immobility, and lack 
of exercise. Survivors of stroke may experience 
increased energy expenditure during gait due to 
the inability to activate normal motor patterns, 
which clarifies the use of the walking test to in-
vestigate the stroke performance during gait.10
So, the aim of this review was to investiga-




A literature search was performed in the 
MedLine (PubMed) databases ranging from 
January 1, 2000 to April 16, 2013. The search 
terms used were stroke (or cerebrovascular 
accident or hemiplegia) and walking (mobility 
limitation). Author number one reviewed the 
titles and/or abstracts of displayed articles 
and determined their relevance to this review. 
Full text copies of relevant articles were obtai-
ned. Reference lists were screened for identi-
fication of other relevant articles. Only articles 
written in English were included in this review.
Inclusion Criteria
Studies were included in the review if 
they: included participants with a diagnosis of 
stroke and the results of the 6MWT to deter-
mine functional capacity. Exclusion criteria for 
this review was the 6MWT not being the focus 
of the study, but with pharmacological inter-
ventions as the study focus.
Data extraction
Information about the study design, set-
ting, participants, and results were extracted 
by the first author and checked by the second 
author.
RESULTS
The electronic search identified 393 arti-
cles. After screening all the titles and abstracts, 
38 articles were identified, but after reviewing 
the full text, 31 articles were included.
Characteristics of included studies
The 31 included studies were divided into 9 
randomized controlled trials, 2 case-control stu-
dies, 5 prospective studies, and 15 cross-sectio-
nal studies and involved 1,824 surviving stroke 
patients, 146 healthy controls, and 38 Multiple 
Sclerosis patients. The results are presented 
separately in Table 1.
The randomized controlled trials are pre-
sented in Table 2.
The characteristics of the prospective stu-
dies are shown in Table 3.
The cross-sectional studies are presented 
in Table 4.
Functional capacity tests
As for functional testing, it is possible to 
verify that the 6MWT was used in conjunc-
tion with the 10MWT in 20.7% of the studies, 
followed by the TUGT, the step test, and exer-
cise tolerance test 10.3%. It was also used in 
a study with the shuttle walk and short walk 
tests (3.4%).
Functional scales
The studies that made use of the 6MWT 
also used different scales and assessment 
tools. The Berg Balance Scale was among the 
most commonly used scales, verified as the 
most frequently used with 31% of the studies, 
followed by 20.6% that used the Barthel index 
and Functional Independence Rankin Score 
to measure, and 10.3% with the Functional 
Ambulation Category 6.8%.
Variables
The variable most often used was the 
distance in 6MWT, but this was associated 
with peak VO
2
 in 17.24% of the studies, with 
gait speed in 6.8%, 3.4% with stride length, 
heart rate with 6.8%, Borg scale in 3.4%, and 
lower limb strength in 10.3% of the studies 
analyzed.
Walking distance
Comparing the distance traveled be-
tween studies in randomized clinical trials, 
the study by Brock et al.16 found the lowest 
values for both the treated group and the 
control group with 102.6 ± 64 and 78.5 ± 61.3 
meters, respectively, whereas Mayo et al.13 
found the greatest distances with 321.1 for 
group experiences, and 321.6 meters for 
the group treated with exercise. The largest 
gains in the distance before and after the 
interventions were found in the study by 
Blennerhassett & Dite19 showing an increase 
of 223 meters for the mobility group and of 
132 meters for the upper limb group. In pros-
pective studies the lowest entered values in 
patients with stroke were from the study by 
Iosa et al.24 with a distance of 94.1 meters 
and the highest values were found by Rose 
et al.20 whose post-stroke individuals traveled 
a distance of 318.8 meters.
In cross-sectional studies, the smallest 
footage was found in the study by Ng and 
Hui-Chan29 with a distance of 183 meters and 
the largest found by Blennerhassett et al.27 
with 463 meters.
Table 1. Number of subjects involved in this review
Type of study Patients Control Other patients
Experimental
Randomized controlled trial 381 0
Observational
Case control study 34 10
Prospective study 640 90
Cross-sectional study 667 46 38
Total 1,722 146 38
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Table 2. Studies of randomized controlled trial characteristics
Study Sample size Age Intervention Studied Variables 6MWD (m) 6MWD difference (m)
Kang et al.11 30 post-stroke 
10 per group (intervention, 
conventional and control)
56.1 ± 7.3 Treadmill training with OFG on 
balance and gait compared 
with TG and CG
6MWT, 10MWT, TUGT OFG: 240, TG: 237, CG: 239 OFG: 24.5 
TG: 4.6 
CG: 1.8
Lam et al.12 52 post-stroke 
20 USA 
32 Germany
66.8 ± 1.1 Prediction of response to T-EX3 
and T-EX6






Mayo et al.13 87 post-stroke 
43 cycle group 
44 exercise group
67.7 ± 13.3 Two home-based exercise 
(cycle group x exercise group) 
programs to improve functional 
walking
6MWT, physical func-
tion, role participation, 
quality of life exercise 
adherence, and 
adverse events
Cycle group: 321.1 
Exercise group: 321.6
Cycle group: 18 
Exercise group: 1
Monticone et al.14 60 sub-acute stroke 
30 regent suit group (RSG) 
30 control group (CG)
61.1 ± 7.9 Compare the regent suit training 
to improve recovery of motor 
and daily living activities with 
the same exercise without the 
regent suit
6MWT, BBS, FIM, BI Used only the gait velocity
Globas et al.15 38 residual hemiparetic gait 
20 TAEX group 
18 control group
68.7 ± 6.4 Compare TAEX or conventional 
care physiotherapy with 3 month 
of rehabilitation to improve 
sustained walking capacity and 
cardiovascular fitness out to a 
1-year follow-up.
6MWT, BBS, RMI, Quality 
of life and peak VO2
TAEX group 332.18 ± 136 
Control group 265.9 ± 189
TAEX group 57.7 
Control group 4.7
Brock et al.16 26 patients 
20 weeks post-stroke
59.9 ± 14 Physiotherapy based on the Bo-
bath concept in conjunction with 
a task practice versus structured 
task practice alone in improve-
ment in walking ability
6MWT, gait velocity, 
BBS
Bobath group: 102.6 ± 64m5 
Control Group: 78.5 ± 61.3
Bobath group: 89.8 
Control Group: 41
Kuys et al.17 24 people with first stroke. 
12 higher-intensity treadmill 
walking, 12 conventional 
physiotherapy
67.5 ± 15.5 Investigate whether HITW during 
rehabilitation is feasible, detri-
mental, or beneficial
6MWT, BI HITW: 177 ± 130 
Control Group 219 ± 180






18 Treadmill training 
16 walking outdoors.
74.5 ± 11.7 Comparing effectiveness of exer-
cise on a treadmill with walking 
outdoors
6MWT, 10MWT, pulse 
rates at rest and in 
activity.
Treadmill training: 277 ± 139 
Walking outdoors 
299.4 ± 159.3




30 stroke subjects 
15 Upper Limb 
15 Mobility Group.
55.1 ± 15.1 Verify whether task-related 
practice improved mobility and 
upper limb function
6MWT, TUGT, ST, JTHFT, 
MAS
Mobility Group 183 ± 84  
Upper Limb 181 ± 85
Mobility Group 233 
Upper Limb 132
6MWD: six minute walk distance; 6MWT: six minute walk test, 10MWT: 10 meters walk test; TUGT: time up and go test; peak VO
2
: peak oxygen consumption; BBS: Berg Balance Scale; FIM: functional impairment measures; 
BI: Barthel Index; RMI: Rivermead Mobility Index, SP: step test; JTHFT: Jebsen Taylor Hand Function Test; MAS: Motor Assessment Scale; OFG: Treadmill training with optic flow; TG: treadmill group; CG: control group; T-EX3: 
treadmill exercises comparing 3; T-EX6: 6 months of the treadmill exercise therapy; TAEX: high-intensity aerobic treadmill exercise; HITW: Investigate if higher-intensity treadmill walking
Table 3. Studies of prospective and case control characteristics
Study Type of study Sample size Age Studied Variables 6MWD (m)
Rose et al.20 Prospective cohort study 469 post-stroke Community-dwelling individuals 62.9 ± 12.7 ETT, 10MWT, LEFM-M, 6MWT 318.8 ± 78.6
Carroll et al.21 Prospective cohort study 50 Independently mobile stroke patients 72.4 ± 12.3 BI, RS, 6MWT; short walk. 158.6 ± 129.2
Mehrholz et al.22 Prospective cohort study 55 non-ambulatory patients after stroke 62.8 ± 10.2 FAC, RMI, walking velocity, step length, 6MWT 112.3 ± 143.9
Simpson et al.23 Case-control study 80 people with stroke 90 controls
Stroke: 67.6 ± 9.9 
Control: 68.4 ± 10 CCSE; BBS, TUGT, 6MWT
Stroke: 275.9 ± 141.8 
Control: 527.08 ± 85.9
Iosa et al.24 Case-control study 20 post-stroke patients 10 controls
Stroke: 64.4 ± 9.7 
Control: 62.8 ± 9.7 BI, FAC, 6MWT
Stroke: 94.1 ± 73 
Control: 226 ± 111
ETT: exercise tolerance test; LEFM-M: Lower Extremity Fugl-Meyer - Motor Assessment; 6MWT: six minute walk test, 10MWT: 10 meters walk test; BI: Barthel Index; RS: Rankin Score; FAC: Functional Ambulation Category; 
RMI: Rivermead Mobility Index; CCSE: Cognitive Capacity Screening Examination; BBS: Berg Balance Scale; TUGT: Timed Up and Go Test
DISCUSSION
This literature review found that the 6MWT 
is effective in evaluating functional capacity. 
Normally the 6MWT was used together with 
the 10MWT; this is important because while 
the 6MWT was used to investigate the walking 
endurance, the 10 MWT was used for testing 
walking speed. Both are necessary to evaluate 
one’s walking capacity.7 In their study, Dalgas 
et al.7 found that the walking speeds of a short 
walking test and a long walking test are very clo-
sely correlated in patients with stroke, whereas 
correlations in healthy subjects were weaker. 
The timed up e/and go test is considering a ba-
sic functional mobility test that has shown good 
construct validity and reliability in assessing the 
basic functional mobility of stroke survivors.
Exercise tolerance needs to be associa-
ted with the 6MWT because, the Pang et al.34 
study found a low correlation between the 
6MWT and VO
2
 peak (r = 0.402). This suggests 
that the 6MWT distance alone should not be 
used to indicate cardiorespiratory fitness in in-
dividuals with chronic stroke.
Because of their being responsive, the 
functional scales should be used to supplement 
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Table 4. Summary of Cross-sectional studies characteristics
Study Sample size Age Studied Variables 6MWD (m)
Van Bloemendaal 
et al.25
75 patients after stroke 58.8 ± 9.8 SWT, 6MWT 472.5 ± 156.1
Rand et al.26 40 people with stroke 66.5 ± 9.6 Chedoke Assessment; BI; FMA, EE, 6MWT 318.8 ± 78.6
Blennerhassett 
et al.27
30 Community-dwelling stroke survivors 66 (49.3-72.0) 6MWT, FSST, ST, EAMQ, FES-I, self-reported falls 463 (266-508)
Schmid et al.28 77 People with stroke 64 ± 8.78 Modified Rankin Scale, 10MWT, 6MWT, BBS, FAB, ABC, MFES 885 ± 430
Ng e Hui-Chan29 62 Subjects with spastic hemiplegia 57.4 ± 7.8 6MWT, Ankle dorsiflexor and plantarflexor strength, CSS 183.7 ± 84.3
Liu et al.30 91 People living in the community with a residual 
walking deficit within the first year of a first or 
recurrent stroke
72 ± 10 BBS, 6MWT 196 ± 119 
197 ± 126
Dalgas et al.7 38 Patients with Multiple sclerosis (MS), 48 patients 
with stroke, and 46 healthy subjects
MS: 48.7 ± 8.8 
Stroke 67.7 ± 8.5 
Heallty: 46.9 ± 12.2
EDSS, FMA, 6MWT, 10MWT MS: 436 ± 144 
Stroke 292 ± 117 
Heallty: 711 ± 71
Sibley et al.31 24 community dwelling, independently ambula-
ting individuals more than 3 months after stroke
63 ± 13 6MWT; BBS, NIH, CMSA, ETT 283.3 ± 136.8
Kosak &Smith32 18 inpatient stroke rehabilitation program 77 ± 11 FIM, 2, 6, 12 MWT unidentified
Severinsen et al.33 48 post-stroke patients 68 ± 9 VO2 peak and isometric knee extensor muscle strength at 
the paretic knee, 6MWT, 10MWT
291 ± 171
Pang et al.34 63 post-stroke patients 65.3 ± 8.7 ETT and a 6MW, VO2 peak, modified Ashworth scale, BBS, 
isometric knee extension strength
370.2 ± 159.2
Tseng & Kluding10 9 people post-stroke 56.8 ± 9 FI; 6MWT, Fugl-Meyer, VO2 peak 295.5 ± 171.4
Muren et al.35 30 subjects with stroke 59 ± 9 HRQoL, 6MWT 353 ± 137
Kluding & Gajewski36 26 people with chronic stroke 55.6 ± 11 6MWT, BBS 202.4 ± 134.3
Ng et al.37 26 people with chronic stroke 58.5 ± 6.1 6MWT with different walkway lengths (10-, 20-, and 30-m 
walkway distances) turning directions (turning to affected 
side and unaffected side); BS, and HR
10 metes: 227.3 ± 79.07 
20 meters: 252.2 ± 5.3 
30 meters: 265.47 ± 9.4
SWT: Shuttle walk test; 6MWT: Six-minute walk test; Chedoke Assessment: Chedoke McMaster Stroke Assessment; FMA: Fulg-Meyer Assessment; EE: energy expenditure; FSST: Four Square Step Test; ST: step test; 
EAMQ: Environmental Analysis of Mobility Questionnaire; FES-I: Falls Efficacy Scale-International; BBS: Berg Balance Scale, FAB: Fullerton Advanced Balance Scale; ABC: Activities-specific Balance Confidence; MFES: Modified 
Falls Efficacy Scale; NIH: National Institutes of Health Stroke Scale CSS: composite spasticity scale; CMSA: sensorimotor recovery; FIM: functional, impairment measure scores, VO
2
 peak: Peak oxygen consumption; FI: fatigue 
index, HRQoL: health-related quality of life, HR: heart rate; ETT: exercise tolerance test; BS: Borg Scale
the evaluation of patients with stroke becau-
se they have good responsiveness. In a sys-
tematic review, Scrivener et al.38 studied the 
responsiveness of lower limb physical perfor-
mance measurements in inpatient care after 
stroke and found a large responsiveness them 
very sensitive, being able to detect changes in 
these patients.
In our study, the scale most used was the 
BBS that has been determined to be valid and 
reliable. The BBS is a physical performance 
measure that includes 14 items designed to 
assess both static and dynamic balance. Bland 
et al.39 found that a Berg Balance Scale score 
of 20 and an FIM walk item score of 1 or 2 at 
admission of rehabilitation indicates that a 
person with stroke is highly likely to achieve 
only household ambulation speeds at dischar-
ge from an inpatient rehabilitation facility.
The BI is a commonly used measurement of 
daily life activities (DLA) for patients with stroke 
that is related to ambulation capacity, as des-
cribed by Saker et al.40 The FIM is considered 
valid and one of the most widely used functio-
nal measurement tools. Measures in rehabilita-
tion facilities use the Functional Independence 
Measure (FIM), which measures degree of 
disability. Performance is measured in the five 
domains of the FIM (Self-care, Sphincter con-
trol, Transfers, Locomotion, and Cognition).41
In the study by Fulk et al.42 the 6MWT 
was strongly to moderately correlated with 
gait speed (r = 0.89), locomotion (walk) FIM 
(r = 0.69), and motor FIM (r = 0.52). The 6MWT 
is a clinically useful measure of post-stroke 
walking ability. It is reliable and is related to 
other measures of walking ability and function 
that are commonly used during rehabilitation 
after stroke.
Independent gait is considered a primary 
goal in stroke rehabilitation. What constitutes 
independent gait is often based on the Func-
tional Ambulation Categories (FAC) classifica-
tion. The FAC instrument is designed to provi-
de information on the level of physical support 
needed by subjects in order to ambulate sa-
fely. This instrument has been found to be re-
liable and valid in classifying hemiplegic gait. 
4-6 Walking speed has been established.43
Despite this use, the 6MWT had different 
results in your distance traveled. This could 
be related with time post stroke or the age 
with difference about 22 year between the 
studies. But it is possible to detect that the 
distance traveled changes with the rehabilita-
tion, as seen in the randomized clinical trials. 
It is important to note that the 6MWT shows 
the functional capacity of ambulation because 
when comparing post stroke volunteers with 
healthy people were is possible detected that 
post stroke walk less.
However, Duncan et al.44 pointed out that 
one of the problems with current stroke out-
come measurement tools is that these tools 
were not always developed specifically for 
stroke. For example, there are a number of 
stroke-specific impairments that could po-
tentially alter the outcome of the functio-
nal walk tests. Individuals with stroke may 
be limited by cardiovascular performance; 
however, factors such as muscle weakness 
(of peripheral and central origin), balance 
impairment, and spasticity could potentially 
influence the distance walked.
CONCLUSION
The 6MWT is useful in evaluating the 
functional capacity in patients with stroke, 
however, it should be used along with other 
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assessment tools to reveal the general profile 
of these patients. More studies are necessary 
to verify and support the factors that influen-
ce the test results.
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